1,857
Views
12
CrossRef citations to date
0
Altmetric
Perspective

SPOP-mediated degradation of BRD4 dictates cellular sensitivity to BET inhibitors

ORCID Icon, &
Pages 2326-2329 | Received 25 Sep 2017, Accepted 02 Oct 2017, Published online: 26 Dec 2017

Figures & data

Figure 1. A schematic model illustrating how SPOP governs the BET protein stability and controls resistance to BET inhibitors. Prostate cancer cells with SPOP mutation exhibited increased resistance to BET inhibitor, where endometrial cancer-associated SPOP mutants lead to sensitization to BET inhibitors in endometrial cancer.

Figure 1. A schematic model illustrating how SPOP governs the BET protein stability and controls resistance to BET inhibitors. Prostate cancer cells with SPOP mutation exhibited increased resistance to BET inhibitor, where endometrial cancer-associated SPOP mutants lead to sensitization to BET inhibitors in endometrial cancer.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.